Increase of IGF-I secretion and bioavailaility during generation test as a prognostic factor of first-year response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests

被引：0

作者：

Smyczynska, Joanna ^{[1
]}

Hilczer, Maciej ^{[1
]}

Stawerska, Renata ^{[1
]}

Lewinski, Andrzej

机构：

[1] Med Univ Lodz, Dept Pediat Endocrinol, Dept Endocrinol & Metab Dis, PMMH RI, Lodz, Poland

来源：

HORMONE RESEARCH | 2008年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：105 / 105

页数：1

共 48 条

[31] Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
Rogol, AD
Blethen, SL
Sy, JP
Veldhuis, JD
CLINICAL ENDOCRINOLOGY, 2003, 58 (02) : 229 - 237
[32] Growth hormone (GH) treatment of children with idiopathic short children (ISS) with normal insulin-like growth factor-1 (IGF-1) versus those with low IGF-I at diagnosis
Elsiddig, Sohair
Soliman, Ashraf
Alaaraj, Nada
Khalil, Ahmed
Ahmed, Hannah
HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 309 - 310
[33] Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial
Midyett, L. Kurt
Rogol, Alan D.
Van Meter, Quentin L.
Frane, James
Bright, George M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 611 - 619
[34] 24-hour secretion of growth hormone (GH), insulinlike growth factors-I and -II (IGF-I, -II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature.
Stratakis, CA
Mastorakos, G
Magiakou, MA
Papavasiliou, EC
PanitsaFaflia, C
Georgiadis, E
Batrinos, ML
ENDOCRINE RESEARCH, 1996, 22 (03) : 261 - 276
[35] Growth hormone therapy of children with idiopathic short stature (ISS), also called non-GH deficient short stature: correlation of efficacy with baseline IGF-I levels (subgroup analysis from the Genentech collaborative group study (GCGS))
Hintz, R.
Bonnemaire, M.
Lippe, B. M.
Liyanage, N.
Loumaye, E.
HORMONE RESEARCH, 2006, 65 : 151 - 151
[36] Prevalence of insulin-like growth factor 1 (IGF1) deficiency in prepubertal children with isolated short stature (ISS) and their response to GH therapy
Elsiddig, Sohair
Soliman, Ashraf
Khalil, Ahmed
Alaaraj, Nada
Ahmed, Hannah
HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 304 - 305
[37] Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature
Imamoglu, S
Bereket, A
Turan, S
Haklar, G
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (01): : 69 - 74
[38] Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease
Soliman, AT
Darwish, A
Mohammed, SH
Bassiony, MR
ElBanna, N
Asfour, M
JOURNAL OF TROPICAL PEDIATRICS, 1995, 41 (05) : 285 - 289
[39] Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency
Thoren, M
Hilding, A
Baxter, RC
Degerblad, M
WivallHelleryd, IL
Hall, K
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01): : 223 - 228
[40] COMPARATIVE EFFECTS OF HUMAN GROWTH-HORMONE (GH) AND INSULIN-LIKE GROWTH FACTOR-I SOMATOMEDIN-C (IGF-I SMC) ON ERYTHROPOIETIC CULTURES FROM NORMAL-CHILDREN
CLAUSTRES, M
CHATELAIN, P
SULTAN, C
PEDIATRIC RESEARCH, 1986, 20 (11) : 1191 - 1191

← 1 2 3 4 5 →